期刊文献+

COX-2与MVD在三阴性乳腺癌中的表达及相关性研究 被引量:6

Expression and correlation of COX-2 and MVD in triple-negative breast carcinoma
下载PDF
导出
摘要 目的:研究COX-2在三阴性乳腺癌中的表达及意义,探讨COX-2与CD31标记的新生微血管密度(MVD)的相关性。方法:采用免疫组化法检测60例三阴性乳腺癌及518例非三阴性乳腺癌组织石蜡标本中的COX-2和MVD的表达情况,并对三阴性乳腺癌与非三阴性乳腺癌的临床病理特征进行比较。结果:①与非三阴性乳腺癌组相比,三阴性乳腺癌组患者年龄偏轻、绝经前患者比例明显升高;三阴性乳腺癌组织分化程度低,组织学分级为Ⅲ级的比例明显升高;②COX-2在三阴性乳腺癌及非三阴性乳腺癌组织中的阳性率分别为73.3%、58.0%,两者存在差异(P<0.05);③三阴性乳腺癌的MVD为183.73±25.64,非三阴性乳腺癌组织中MVD为168.84±24.07,两者间具有显著差异(P<0.01);④COX-2与MVD在三阴性乳腺癌中的表达具有显著相关性(P<0.01)。结论:三阴性乳腺癌组织分化差,恶性程度高,COX-2表达和MVD在三阴性乳腺癌中显著增高,两者可能共同参与三阴性乳腺癌的发生、发展,检测COX-2和MVD可作为反映三阴性乳腺癌临床及病理学特点的参考指标,同时可考虑将COX-2作为三阴性乳腺癌治疗的新靶点。 Objective:To study the expression and significance of COX-2 in triple-negative breast carcinoma (TNBC) and explore the relevance of COX-2 and neovascularization (MVD) marked by CD31. Methods:The expression of COX-2,MVD in 60 TNBC cases and 518 paraffin wax samples of non-TNBC patients were detected by immuno-histochemical method,and the clinical characteristics of TNBC cases and non-TNBC cases were compared. Results: (1)Compared with non-TNBC patients, TNBC cases were younger and mostly premenopausal patients,the differentiation of TNBC was lower while the percentage of histology graded Ⅲ was significantly increased; (2)The positive rate of COX-2 in 60 cases of TNBC was 73.3%, and that in 518 cases of the non-TNBC was 58.0%. The difference is statistically significant(P 〈 0.05) ;(3)In 60 cases of TNBC,the value of MVD (CD31 marked)was 183.73 ± 25.64,in 518 cases of non-TNBC,MVD was 168.84±24.07 (P 〈 0.01); @The expression of COX-2 in TNBC was significantly correlated with CD31 (P 〈 0.01). Conclusion:The high expression of COX-2 and MVD are closely associated with infiltration and metastasis of TNBC, thus the abnormal expression of COX-2 and MVD are likely to participate together in the genesis and progress of TNBC.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第10期1410-1414,共5页 Journal of Nanjing Medical University(Natural Sciences)
关键词 三阴性乳腺癌 免疫组化 COX-2 MVD triple negative breast carcinoma(TNBC ) immunohistochemistry COX-2 MVD
  • 相关文献

参考文献14

  • 1Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature,2000,406(6797): 747-752.
  • 2Dannenberg AJ, Lippman SM, MannJR, et al. Cyclooxy?genase-2 and epidermal growth factor receptor- pharma?cologic targets for chemo -prevention[J].J Clin Oncol, 2005,23(2):254-266.
  • 3Oliveras-Ferraros C, Vazquez-Martin A, Lopez-Bonet E, et al. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agentcis?platin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer[J]. IntJ Oncol, 2009, 33( 6): 1165-1176.
  • 4Corkery B, CrownJ, Clynes M, et al. Epidermal growth factor receptor as a potential therapeutic target in triple?negative breast cancer[J]. Ann Oncol ,2009 , 20(7) :862- 867.
  • 5蔡铭泉,陈强,施纯枚.受体三阴性乳腺癌的研究进展[J].临床肿瘤学杂志,2009,14(3):283-287. 被引量:17
  • 6Lu S, Yu G, Zhu Y, et al. Cyclooxygenase-2 overexpres?sion in MCF-lOF human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation[J]. Int Cancer, 2005 , 116 ( 6 ) : 847- 852.
  • 7Sivula A, Talvensaari-Mattila A,LundinJ ,et al. Associa?tion of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer[J]'Breast Cancer Res Treat, 2005,89(3) : 215-220.
  • 8Ristimaki A, Sivula A, LundinJ, et al. Prognostic signifi?cance of ele-vated cyclooxygenase-2 expression in breast cancer[J]. Cancer Res ,2002, 62(3) :632-635.
  • 9Toyoshima T, Kamijo R, Takizawa K, et al. Inhibitorofcy?clooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regu- lation of cyclin dependent kinase inhibitor p21[J]. BrJ Cancer,2002,86(7): 1150- 1156.
  • 10ZhuJ, HuangJW ,Tseng PH, et al. From the cyclooxyge?nase-2 inhibit-orcelecoxibto a novel class of 3-phospho?inositide- dependent- protein kinase-1 inhibitors[J]. Cancer Res ,2004 , 64( 12) :4309-4318.

二级参考文献42

  • 1Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[ J]. Nature ,2000,406 : 747 - 752.
  • 2Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochenical and clinical characterization of the basal-like subtype of invasive breast carcinoma [ J ]. Clin Cancer Res, 2004,10 ( 16 ) :5367 - 5374.
  • 3Bertucci F. How basal are triple-negative breast cancers? [ J]. Int J Cancer,2008,123 ( 1 ) : 936 - 240.
  • 4Sasa M, Bando Y,Takahashi M, et al. Screening for basal marker expression is necessary for decision of therapeutic strategy tbr triple-negative breast cancer [ J ]. J Surg Oncol, 2008,97 ( 1 ) : 30-34.
  • 5Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options [ J ]. Lancet Oncol,2007,8 : 235 - 244.
  • 6Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCAI mutations and a basal epithelial phenotype in breast cancer[J]. J Natl Cancer Inst,2003,95 : 1482 - 1485.
  • 7Korsehing E, Packeisen J, Agelopoulos K,et al. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenelic pathways of breast carcinogenesis[ J ]. Lab Invest,2002,82 : 1525 - 1533.
  • 8Foulkes WD, Brunet JS, Stefansson IM,et al. The prognostic implication of the basal-like (cyclin E^high/p27^low/p53^+/ glomeruloid-microvascular-proliferation^+ ) phenotype of BRCA1-related breast cancer[ J]. Cancer Res,2004, 64 : 830 - 835.
  • 9Bergamaschi A, Kim YH,Wang P,et al. Distinct patterns of DNA copy number alteration are associated with different clinieopathological features and gene-expression subtypes of breast cancer [ J]. Genes Chromosomes Cancer, 2006,45 : 1033 - 1040.
  • 10Turner N, Tutt A, Ashworth A. Hallmarks of BRCkness' in sporadic caneers[J]. Nat Rev Cancer,2004-,4:814 -819.

共引文献16

同被引文献36

引证文献6

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部